Billion To One

Molecular diagnostics platform, using proprietary technology to develop diagnostic tests for pre-natal and oncology.
Founder(s)
Oguzhan Atay, PhD and David Tsao, PhD
SECTOR(S)
Healthcare
Investment Stage
Growth
Status
Private